Neurogene Inc (NGNE)

Jun 13, 2025

BMO Capital Markets Issues Positive Forecast for Neurogene (NASDAQ:NGNE) Stock Price - Defense World

Jun 13, 2025

Jun 12, 2025

Neurogene (NGNE) Price Target Raised by BMO Capital | NGNE Stock News - GuruFocus

Jun 12, 2025

Jun 12, 2025

Neurogene Approves Amendments at Annual Stockholders Meeting - TipRanks

Jun 12, 2025

Jun 11, 2025

Neurogene price target raised to $26 from $22 at BMO Capital - Investing.com Canada

Jun 11, 2025

Jun 11, 2025

Neurogene Inc. (NASDAQ:NGNE) Receives $44.60 Consensus PT from Brokerages - Defense World

Jun 11, 2025

Jun 10, 2025

Two Sigma Investments LP Invests $472,000 in Neurogene Inc. (NASDAQ:NGNE) - Defense World

Jun 10, 2025

Jun 09, 2025

Neurogene Highlights Gene Therapy Advancements in New Update - TipRanks

Jun 09, 2025

Jun 08, 2025

Neurogene Inc. (NASDAQ:NGNE) Stock Position Lifted by Wellington Management Group LLP - Defense World

Jun 08, 2025

Jun 06, 2025

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bluefield Daily Telegraph

Jun 06, 2025

Jun 06, 2025

Squarepoint Ops LLC Has $398,000 Holdings in Neurogene Inc. (NASDAQ:NGNE) - Defense World

Jun 06, 2025

Jun 05, 2025

BNP Paribas Financial Markets Cuts Stake in Neurogene Inc. (NASDAQ:NGNE) - Defense World

Jun 05, 2025

May 30, 2025

Neurogene Reports Q1 2025 Financial Progress and Updates - TipRanks

May 30, 2025

May 26, 2025

Northern Trust Corp Buys 5,845 Shares of Neurogene Inc. (NASDAQ:NGNE) - Defense World

May 26, 2025

May 22, 2025

BMO Capital Markets Forecasts Strong Price Appreciation for Neurogene (NASDAQ:NGNE) Stock - Defense World

May 22, 2025

May 21, 2025

Deutsche Bank AG Sells 181,997 Shares of Neurogene Inc. (NASDAQ:NGNE) - Defense World

May 21, 2025

May 20, 2025

Neurogene (NGNE) Receives Price Target Boost from BMO Capital | - GuruFocus

May 20, 2025

May 20, 2025

Neurogene (NGNE) Receives Price Target Boost from BMO Capital | NGNE Stock News - GuruFocus

May 20, 2025

May 19, 2025

Neurogene stock target raised to $22 by BMO Capital - Investing.com Nigeria

May 19, 2025

May 19, 2025

ASGCT Roundup: Sarepta, Rocket, Neurogene and the World’s First Tailored CRISPR Therapy - NewsBreak: Local News & Alerts

May 19, 2025

May 19, 2025

Neurogene introduces gene therapy monitoring system after patient death - Yahoo Finance

May 19, 2025

May 18, 2025

Neurogene (NASDAQ:NGNE) Stock Rating Lowered by Robert W. Baird - Defense World

May 18, 2025

May 18, 2025

Baird R W Downgrades Neurogene (NASDAQ:NGNE) to Hold - Defense World

May 18, 2025

May 17, 2025

Neurogene presents HLH treatment strategy at ASGCT meeting By Investing.com - Investing.com Nigeria

May 17, 2025

May 17, 2025

Brokerages Set Neurogene Inc. (NASDAQ:NGNE) Target Price at $46.20 - Defense World

May 17, 2025

May 16, 2025

Neurogene Shares Drop After Downgrade From Baird - marketscreener.com

May 16, 2025

May 16, 2025

This Foot Locker Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday - Benzinga

May 16, 2025

May 16, 2025

Neurogene stock downgraded at Baird (NGNE:NASDAQ) - Seeking Alpha

May 16, 2025

May 16, 2025

Neurogene (NGNE) Downgraded to Neutral with Lowered Price Target | NGNE Stock News - GuruFocus

May 16, 2025

May 16, 2025

Neurogene (NGNE) Presents New Protocol for Tackling Gene Therapy - GuruFocus

May 16, 2025

May 16, 2025

Neurogene presents HLH treatment strategy at ASGCT meeting - Investing.com Australia

May 16, 2025

May 16, 2025

Neurogene Announces Evidence-Based Monitoring And Treatment Intended To Reverse Rare Hyperinflammatory Syndrome Associated With High-Dose Aav - marketscreener.com

May 16, 2025

May 16, 2025

Neurogene (NGNE) Presents New Protocol for Tackling Gene Therapy Complication | NGNE Stock News - GuruFocus

May 16, 2025

May 16, 2025

Neurogene Announces Evidence-Based Monitoring and Treatment Intended to Reverse Rare Hyperinflammatory Syndrome Associated with High-Dose AAV - Eagle-Tribune

May 16, 2025

May 16, 2025

Neurogene (NGNE) Downgraded by Baird Amid Regulatory Concerns | - GuruFocus

May 16, 2025

May 16, 2025

Baird cuts Neurogene stock rating, lowers price target to $24 By Investing.com - Investing.com Nigeria

May 16, 2025

May 16, 2025

Neurogene (NGNE) Downgraded by Baird Amid Regulatory Concerns | NGNE Stock News - GuruFocus

May 16, 2025

May 16, 2025

Baird cuts Neurogene stock rating, lowers price target to $24 - Investing.com

May 16, 2025

May 16, 2025

Q2 Earnings Estimate for Neurogene Issued By HC Wainwright - Defense World

May 16, 2025

May 15, 2025

Rett Syndrome treatment Market Is Booming Worldwide 2025-2032 | - openPR.com

May 15, 2025

May 15, 2025

HC Wainwright Has Lowered Expectations for Neurogene (NASDAQ:NGNE) Stock Price - Defense World

May 15, 2025

May 13, 2025

Neurogene (NGNE) Analyst Rating Update: Target Price Adjusted | - GuruFocus

May 13, 2025

May 13, 2025

Neurogene (NGNE) Target Price Reduced, Buy Rating Maintained | N - GuruFocus

May 13, 2025

May 11, 2025

Wells Fargo & Company MN Purchases 1,397 Shares of Neurogene Inc. (NASDAQ:NGNE) - Defense World

May 11, 2025

May 10, 2025

Barclays PLC Has $401,000 Position in Neurogene Inc. (NASDAQ:NGNE) - Defense World

May 10, 2025

May 10, 2025

Neurogene: Q1 Earnings Snapshot - San Francisco Chronicle

May 10, 2025

May 09, 2025

Neurogene Reports Q1 2025 Financial Results and Advances Rett Syndrome Gene Therapy - TipRanks

May 09, 2025